The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
Recap by typeshit. Full story at Il Sole 24 ORE.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
6:45
Kim Constable gives her take on peptides aimed at women past 40. Her claims are her own, so watch with that in mind.
The think tank argues regulated compounding beats 'research use only' sellers, noting an FDA panel voted to add six peptides despite staff advising against all seven.
NSW peptide hospitalisations went from five in July 2025 to over 200 in September 2026, and needle programs say syringe machines are emptying within hours.
Loading…